Corcept Therapeutics Incorporated (CORT)
Net profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 140,686 | 141,295 | 125,983 | 118,023 | 106,140 | 91,386 | 94,616 | 94,500 | 101,418 | 116,870 | 112,733 | 111,844 | 112,512 | 106,453 | 97,607 | 99,411 | 106,011 | 109,398 | 114,113 | 105,972 |
Revenue (ttm) | US$ in thousands | 675,040 | 628,555 | 569,610 | 523,529 | 482,375 | 450,026 | 428,153 | 413,824 | 401,858 | 397,624 | 392,027 | 380,229 | 365,978 | 352,891 | 343,087 | 340,064 | 353,874 | 356,034 | 351,212 | 334,904 |
Net profit margin | 20.84% | 22.48% | 22.12% | 22.54% | 22.00% | 20.31% | 22.10% | 22.84% | 25.24% | 29.39% | 28.76% | 29.41% | 30.74% | 30.17% | 28.45% | 29.23% | 29.96% | 30.73% | 32.49% | 31.64% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $140,686K ÷ $675,040K
= 20.84%
Net profit margin measures the percentage of revenue that translates into net income after all expenses are deducted. Corcept Therapeutics Incorporated has demonstrated a generally stable net profit margin over the period from March 31, 2020, to December 31, 2024. The company's net profit margin ranged from a high of 32.49% in June 30, 2020, to a low of 20.31% in September 30, 2023, before showing some improvement in the following periods.
Overall, the trend indicates that the net profit margin has been gradually decreasing from the initial high levels observed in 2020. This could be a sign of increasing operating expenses or declining revenues relative to the costs incurred by the company. It is noteworthy that the net profit margin has fluctuated within a certain range, with some periods showing slight improvements while others experienced declines.
Investors and analysts may want to further investigate the factors contributing to the variation in Corcept Therapeutics' net profit margin over time to assess the company's profitability and efficiency in managing expenses. Monitoring the trend of the net profit margin can provide insights into the company's financial health and sustainability in generating profits.
Peer comparison
Dec 31, 2024